Concepedia

Author

Conrad Tou

AstraZeneca (United States)

Also Known As

Conrad K. P. Tou, Conrad K.P. Tou, Conrad Tou

12

Publications

938

Citations

10

H-Index

12

Concepts

All Affiliations

AstraZeneca (United States)AstraZeneca (Sweden)Chinese People's Liberation ArmyChina-Japan Friendship HospitalAstraZeneca (Germany)
CT

About

Conrad Tou is an author at AstraZeneca (United States) specializing in medicine, metabolic syndrome, and diabetes.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

185

2

Diabetes

2

2

111

3

Public Health

1

1

15

4

Health Policy

1

1

15

5

Nutrition

1

1

15

Conrad Tou

×

10

Publications

937

Citations

10

H-Index

YearCitations

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis

Stanton Goldman, John S. Holcenberg, Jerry Z. Finklestein,

Blood

2001

472

Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: A randomized controlled trial

Wenying Yang, Chang Yu Pan, Conrad Tou,

Diabetes Research and Clinical Practice

2011

96

Clinical trial of extended-release felodipine in pediatric essential hypertension

Howard Trachtman, Rachel Frank, John D. Mahan,

Pediatric Nephrology

2003

75

Efficacy and safety of saxagliptin in drug‐naïve Asian patients with type 2 diabetes mellitus: a randomized controlled trial

Chang Yu Pan, Wenying Yang, Conrad Tou,

Diabetes/Metabolism Research and Reviews

2011

75

Effect of tesaglitazar, a dual PPARα/γ agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12‐week dose-ranging trial

Barry J. Goldstein, Julio Rosenstock, Deborah Anzalone,

Current Medical Research and Opinion

2006

69

Efficacy, safety and tolerability of tesaglitazar when added to the therapeutic regimen of poorly controlled insulin-treated patients with type 2 diabetes

Robert E. Ratner, Shamik Parikh, Conrad Tou

Diabetes and Vascular Disease Research

2007

53

Evaluation of the effect of dapagliflozin on cardiac repolarization: a thorough QT/QTc study

Glenn Carlson, Conrad Tou, Shamik Parikh,

Diabetes Therapy

2011

36

Antihypertensive Efficacy of Candesartan‐Lisinopril in Combination vs. Up‐Titration of Lisinopril: The AMAZE Trials

Joseph L. Izzo, Marc S. Weinberg, James W. Hainer,

Journal of Clinical Hypertension

2004

32

Saxagliptin as initial therapy in treatment-naive Indian adults with type 2 diabetes mellitus inadequately controlled with diet and exercise alone: a randomized, double-blind, placebo-controlled, phase IIIb clinical study

K.M. PRASANNA KUMAR, Sunil Jain, Conrad Tou,

International Journal of Diabetes in Developing Countries

2014

15

Pharmacokinetic Study of Saxagliptin in Healthy Chinese Subjects

Haiyan Li, Yang Li, Conrad Tou,

Clinical Drug Investigation

2012

14

Page 1